Minims (Cyclopentolate Hydrochloride)

Cyclopentolate is used in ophthalmology to facilitate examination of the anterior segment of the eye.

• Diagnostic eye examinations: induces mydriasis to allow clear view of intra‑ocular structures.
• Pediatric ophthalmic assessments: provides cycloplegia to temporarily suspend accommodation for accurate refraction.
• Pre‑operative ocular evaluation: creates a stable, dilated pupil for surgical planning.

• Cyclopentolate Hydrochloride acts as a reversible, non‑selective antagonist of muscarinic acetylcholine receptors in the eye. By blocking these receptors, it relaxes the sphincter pupillae muscle, producing mydriasis, and the ciliary muscle, causing cycloplegia, thereby facilitating detailed ocular examination and measurement.

Cyclopentolate may cause a range of ocular and systemic reactions.

Common Side Effects

• Transient stinging or burning sensation upon instillation.
• Mild conjunctival hyperemia (redness).
• Temporary blurred vision due to pupil dilation.
• Light sensitivity (photophobia).
• Slight increase in intra‑ocular pressure in susceptible individuals.

Serious or Rare Side Effects

• Acute angle‑closure glaucoma.
• Persistent mydriasis lasting several days.
• Systemic anticholinergic effects such as dry mouth, tachycardia, or confusion, especially in the elderly.
• Allergic contact dermatitis of the eyelid skin.
• Severe ocular pain or corneal ulceration.

Before using Cyclopentolate, consider the following safety measures.

• Contraindication: Avoid in patients with known hypersensitivity to cyclopentolate or other anticholinergics.
• Caution: Use carefully in individuals with narrow-angle glaucoma or a history of intra‑ocular pressure spikes.
• Pregnancy: Discuss potential risks with a healthcare professional; use only if clearly needed.
• Breastfeeding: Evaluate benefits versus risks; cyclopentolate may be excreted in milk.
• Pediatric use: Dose and frequency should be determined by an ophthalmologist experienced in pediatric care.
• Store at ambient temperature: keep in the original container, protect from light and moisture.

Cyclopentolate can interact with other medications that affect cholinergic pathways or intra‑ocular pressure.

Major Interactions (Avoid)

• Other potent anticholinergic agents (e.g., atropine) – may increase systemic anticholinergic load.
• Drugs that raise intra‑ocular pressure (e.g., corticosteroid eye drops) – risk of acute glaucoma.

Moderate Interactions (Monitor Closely)

• Systemic antihistamines or tricyclic antidepressants – may potentiate anticholinergic side effects.
• Beta‑blocker eye drops – may mask cycloplegic effect on pupil size.
• Topical anesthetics – may enhance ocular irritation when used together.